Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1142750/000114275018000013/amn-20180630x10q.htm
May 2022
May 2022
March 2022
February 2022
January 2022
December 2021
November 2021
November 2021
October 2021
August 2021
Q2 2018 | % Change Q2 2017 | YTD June 30, 2018 | % Change YTD June 30, 2017 | |
Revenue | $558.1 | 14% | $1,080.6 | 10% |
Gross profit | $181.0 | 12% | $348.8 | 8% |
Net income | $35.5 | 14% | $78.2 | 24% |
Diluted EPS | $0.73 | 16% | $1.60 | 25% |
Adj. diluted EPS* | $0.83 | 24% | $1.64 | 26% |
Adjusted EBITDA* | $70.1 | 4% | $136.6 | 5% |
• | AMN Healthcare reached record highs for revenue and adjusted EPS in the quarter. |
• | Second quarter consolidated revenue of $558 million increased 14% year over year, with organic growth of 7%. |
• | Growth was led by our Nurse and Allied Solutions segment with revenue up by 11% year over year. |
• | Adjusted EBITDA of $70 million grew 4% year over year and was 12.6% of revenue. |
• | Operating cash flow in the second quarter was $66 million. In the first half of 2018, cash flow from operations totaled $126 million, up 80% year over year. |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1142750/000114275018000013/amn-20180630x10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Amn Healthcare Services Inc.
Amn Healthcare Services Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Rating
Learn More![]()
security breaches and other disruptions that could compromise our information and expose us to liability, which could cause our business and reputation to suffer and could subject us to substantial liabilities
The 20% effective tax rate in the six months ended June 30, 2018 differs from our estimated annual effective income tax rate of 24% primarily due to a discrete tax benefit of $5.1 million in the six months ended June 30, 2018 relating to the application of ASU 2016-09, Stock Compensation - Improvements to Employee Share-Based Payment Accounting and the net tax benefit recorded in the six months ended June 30, 2018 relating to COLI as discussed above.
Gross profit increased 12% to $181.0 million for the three months ended June 30, 2018 from $161.0 million for the same period in 2017, representing gross margins of 32.4% and 32.9%, respectively.
Gross profit increased 8% to $348.8 million for the six months ended June 30, 2018 from $322.8 million for the same period in 2017, representing gross margins of 32.3% and 32.8%, respectively.
SG&A expenses broken down among...Read more
SG&A expenses broken down among...Read more
Of the $39.6 million increase,...Read more
The gross margin for the...Read more
The gross margin for the...Read more
Income tax expense was $12.9...Read more
Income tax expense was $20.1...Read more
Amortization expense increased 41% to...Read more
Amortization expense increased 18% to...Read more
These positives were partly offset...Read more
These positives were partly offset...Read more
Although these changes are expected...Read more
The increase was primarily due...Read more
disruption to or failures of...Read more
MedPartners provides mid-revenue cycle management...Read more
Net of these factors, our...Read more
Net of these factors, our...Read more
the effect of investigations, claims,...Read more
the ability of our clients...Read more
As an innovative workforce solutions...Read more
Of the $37.2 million increase,...Read more
We currently estimate our annual...Read more
We currently estimate our annual...Read more
We will adopt this standard...Read more
This standard is effective for...Read more
We work to pass these...Read more
The year over year increase...Read more
The year over year increase...Read more
The increase is primarily due...Read more
The ASU becomes effective for...Read more
our substantial indebtedness and any...Read more
Depreciation expense increased 24% to...Read more
Depreciation expense increased 19% to...Read more
The increase in net cash...Read more
The difference in the effective...Read more
The difference in the effective...Read more
our increasing dependence on third...Read more
Nurse and allied solutions segment...Read more
Other workforce solutions segment revenue...Read more
Nurse and allied solutions segment...Read more
Other workforce solutions segment revenue...Read more
Net cash provided by financing...Read more
a result of our ongoing...Read more
As of June 30, 2018,...Read more
Locum tenens solutions segment revenue...Read more
The FASB recently issued guidance...Read more
The increase is primarily due...Read more
Borrowings under the Senior Credit...Read more
The $0.9 million decrease was...Read more
The $0.7 million decrease was...Read more
We believe that cash generated...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Amn Healthcare Services Inc provided additional information to their SEC Filing as exhibits
Ticker: AMN
CIK: 1142750
Form Type: 10-Q Quarterly Report
Accession Number: 0001142750-18-000013
Submitted to the SEC: Fri Aug 03 2018 4:12:41 PM EST
Accepted by the SEC: Fri Aug 03 2018
Period: Saturday, June 30, 2018
Industry: Help Supply Services